Literature DB >> 35241816

Association of circulating calciprotein particle levels with skeletal muscle mass and strength in middle-aged and older adults.

Masaki Yoshioka1,2, Keisei Kosaki3, Masahiro Matsui1,2, Naoya Okabe1, Chie Saito4, Kunihiro Yamagata4,5, Makoto Kuro-O6, Seiji Maeda7,8.   

Abstract

Calciprotein particles (CPPs) are tiny mineral-protein aggregates consisting of calcium-phosphate and fetuin-A. Recent studies have suggested that CPPs may contribute to the pathogenesis of chronic inflammation and arteriosclerosis. Reduced skeletal muscle mass and strength reportedly contribute independently to increased serum phosphate levels. This finding suggests that reduced skeletal muscle mass and strength can endogenously induce an increase in circulating CPP levels. Therefore, we investigated the potential association between circulating CPP levels and skeletal muscle mass and strength in middle-aged and older adults. One hundred eighty-two middle-aged and older adults (age, 46-83 years) were included in this cross-sectional study (UMIN000034741). Circulating CPP levels were measured using the gel filtration method. Appendicular skeletal muscle mass was assessed using multifrequency bioelectrical impedance analysis with a tetrapolar eight-point tactile electrode system. The skeletal muscle mass index was calculated from appendicular skeletal muscle mass and height. Handgrip and knee extension strengths were used as measures of skeletal muscle strength. The skeletal muscle mass index was negatively correlated with circulating CPP levels (r = -0.31; P < 0.05). This association remained significant after adjustment for potential covariates (β = -0.34; P < 0.05). In contrast, skeletal muscle strength, represented by handgrip strength and knee extension strength, was not significantly associated with circulating CPP levels. In middle-aged and older adults, a lower skeletal muscle mass index was independently associated with higher circulating CPP levels. The present results suggest that maintaining skeletal muscle mass may prevent an increase in circulating CPP levels.
© 2022. The Author(s), under exclusive licence to The Japanese Society of Hypertension.

Entities:  

Keywords:  Aging; Calciprotein particle; Cardiovascular disease; Phosphate metabolism; Skeletal muscle wasting

Mesh:

Year:  2022        PMID: 35241816     DOI: 10.1038/s41440-022-00870-y

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  40 in total

Review 1.  Cardiovascular calcification: artificial intelligence and big data accelerate mechanistic discovery.

Authors:  Maximillian A Rogers; Elena Aikawa
Journal:  Nat Rev Cardiol       Date:  2019-05       Impact factor: 32.419

2.  Prevention: some important steps forward, but many unmet needs in a world with cardiovascular disease as the leading cause of death.

Authors:  Thomas F Lüscher
Journal:  Eur Heart J       Date:  2016-11-07       Impact factor: 29.983

Review 3.  Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism.

Authors:  Ming Chang Hu; Kazuhiro Shiizaki; Makoto Kuro-o; Orson W Moe
Journal:  Annu Rev Physiol       Date:  2013       Impact factor: 19.318

4.  Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD.

Authors:  Edward R Smith; Martin L Ford; Laurie A Tomlinson; Chakravarthi Rajkumar; Lawrence P McMahon; Stephen G Holt
Journal:  Nephrol Dial Transplant       Date:  2011-11-20       Impact factor: 5.992

5.  Serum fetuin-A concentration and fetuin-A-containing calciprotein particles in patients with chronic inflammatory disease and renal failure.

Authors:  Edward R Smith; Michael M Cai; Lawrence P McMahon; Eugenie Pedagogos; Nigel D Toussaint; Catherine Brumby; Stephen G Holt
Journal:  Nephrology (Carlton)       Date:  2013-03       Impact factor: 2.506

6.  Fetuin-mineral complex reflects extraosseous calcification stress in CKD.

Authors:  Takayuki Hamano; Isao Matsui; Satoshi Mikami; Kodo Tomida; Naohiko Fujii; Enyu Imai; Hiromi Rakugi; Yoshitaka Isaka
Journal:  J Am Soc Nephrol       Date:  2010-10-14       Impact factor: 10.121

7.  Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles.

Authors:  Alexander Heiss; Alexander DuChesne; Bernd Denecke; Joachim Grötzinger; Kazuhiko Yamamoto; Thomas Renné; Willi Jahnen-Dechent
Journal:  J Biol Chem       Date:  2003-01-29       Impact factor: 5.157

Review 8.  Vascular calcification: mechanisms and clinical ramifications.

Authors:  Moeen Abedin; Yin Tintut; Linda L Demer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-05-20       Impact factor: 8.311

Review 9.  The Klotho proteins in health and disease.

Authors:  Makoto Kuro-O
Journal:  Nat Rev Nephrol       Date:  2019-01       Impact factor: 28.314

10.  Phosphate as a Pathogen of Arteriosclerosis and Aging.

Authors:  Makoto Kuro-O
Journal:  J Atheroscler Thromb       Date:  2020-10-08       Impact factor: 4.928

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.